Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-02-08
1992-06-30
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514 81, 514261, 514269, 514 86, 544243, 544254, 544265, 544277, 544309, 544317, 544323, 558 57, 556443, 568670, 568839, 560123, 560 8, C07D47102, C07D47318
Patent
active
051263459
ABSTRACT:
Antiviral activity is exhibited by compounds having the formula ##STR1## and its pharmaceutically acceptable salts wherein R.sub.1 is ##STR2## R.sub.6 is hydrogen, alkyl, substituted alkyl, or aryl; and R.sub.7 and R.sub.8 are independently hydrogen, ##STR3##
REFERENCES:
patent: 4177348 (1979-12-01), Shealy et al.
patent: 4232154 (1980-11-01), Shealy et al.
patent: 4543255 (1985-09-01), Shekley et al.
patent: 4617304 (1986-10-01), Ashton et al.
patent: 4743689 (1988-05-01), Shimada et al.
patent: 4782062 (1988-11-01), Tolman et al.
patent: 4801710 (1989-01-01), MacCoss et al.
patent: 4855466 (1989-08-01), Zahler et al.
patent: 4918075 (1990-04-01), Zahler et al.
patent: 4968674 (1990-11-01), Taniyama et al.
patent: 4988703 (1991-01-01), Norbeck et al.
patent: 5064961 (1991-11-01), Bisacchi et al.
Norbeck et al., Chem. Abstr., vol. 113, Entry 212577v (1990) abstracting EP 366059.
N. Shimada et al., Oxetanocin, A Novel Nucleoside from Bacteria, Nov. 1986, J. Antibiotics 39, p. 1623.
H. Nakamura et al., The X-Ray Structure Determination of Oxetanocin, Nov. 1986, J. Antibiotics, 39, p. 1626.
H. Hoshino et al., Inhibition of Infectivity of Human Immunodeficiency Virus by Oxetanocin, Jul. 1987, J. Antibiotics, 40, p. 1077.
S. Niitsuma et al., Studies on the Total Synthesis of Oxetanocin; Tetrahedron Letters, vol. 28, pp. 4713-4714, May 1987.
G. N. Austin et al., Chiral Oxetanes from Sugar Lactones, Tetrahedron Letters, vol. 28, pp. 4741-4744, May 1987.
N. Shimada et al.-Derivatives of Oxetanocin: Oxetanocins, H, X and G, and 2-Aminooxetanocin A, J. Antibiotics, vol. 40, p. 1789, Dec. 1987.
Walton, "3-Methylenecyclobutyl, Cyclopent-3-enyl . . .", J. Chem. Soc., Perkin Trans II, 1987, pp. 231-235.
Kirmse et al., "2-Oxabicyclo[2.1.1]hexan . . .", Chemische Berichte, vol. 121, No. 5, 1988, pp. 1013-1016.
Hanack et al., "Solvolysan von delta.sup.2 -cyclobutylmethyltosylat", Chemische Berichte, vol. 100, No. 6, 1967, pp. 2107-2116.
DeClerq, "Pyrimidine Nucleoside Analogs as Antiviral Agents", Targets for the Design of Antiviral Agents, 1983, pp. 203-230.
Bamford et al., "Synthesis and Antiviral Activity . . .", J. Med. Chem., 1990, vol. 33, pp. 2494-2501.
Kono et al., "Substrate Specificity of a Thymidine . . .", Chem. Pharm. Bull., vol. 32 (1984), pp. 1919-1921.
March, "Advanced Organic Chemistry", 3rd Edition, 1985, p. 129.
Derwent Abstract of Japan 22-08295z, (1987).
Niitsuma et al., "Studies on the Total Synthesis . . .", Tetrahedron Letters, vol. 28, pp. 3967-3970 (1987).
Marquez et al., "Carbocyclic Nucleosides", Medicinal Research Review, vol. 6, pp. 1-16 and 36-40.
Shealy et al., "Synthesis and Antiviral Activity . . .", J. Med. Chem., vol. 27, pp. 1416-1421 (1984).
Slusarchyk William A.
Zahler Robert
Daus Donald G.
Davis Stephen B.
E. R. Squibb & Sons Inc.
LandOfFree
Bis (hydroxymethyl) cyclobutyl triazolopyrimidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bis (hydroxymethyl) cyclobutyl triazolopyrimidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bis (hydroxymethyl) cyclobutyl triazolopyrimidines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1863946